A large-scale, real-world analysis of 15,639 patients treated with Collagenase SANTYL Ointment underscores the clinical and economic benefits of early enzymatic debridement in wound management. Using ...
FORT WORTH, Texas and PETERBOROUGH, Ontario, Jan. 26 Healthpoint today announced that it will begin marketing Collagenase SANTYL® Ointment to healthcare professionals in Canada. SANTYL® Ointment is a ...
YAVNE, Israel, Feb. 12, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair today announced the results of head-to-head ...
Results demonstrate superiority of EscharEx®, a bromelain-based gel vs. SANTYL®, a collagenase ointment, in wound debridement, promotion of granulation tissue, and time to wound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback